WSJ What's News: Trump Weighs Naming Next Fed Chair Early to Undermine Powell Release Date: June 26, 2025
The latest episode of WSJ's "What's News" delves into a spectrum of pressing issues affecting global markets, politics, and public health. Hosted by Luke Vargas, the episode delivers in-depth analysis on President Donald Trump's potential early nomination of a successor to Federal Reserve Chair Jerome Powell, the implications of shifting pharmaceutical trade dynamics with Ireland, and significant movements in the technology sector, particularly concerning Nvidia's expansion into cloud computing. Additionally, the podcast touches upon changes in vaccine advisory practices in the United States and recent developments in the energy sector.
1. Trump’s Potential Early Nomination of Fed Chair Jerome Powell
Strategic Undermining of Powell (00:59)
The episode opens with a Wall Street Journal exclusive about President Donald Trump's consideration of an early nomination for the next Federal Reserve Chair, a strategic move aimed at undermining current chair Jerome Powell. Finance Editor Alex Frankos explains that Powell has faced mounting pressure due to the Federal Reserve's cautious approach to cutting interest rates.
Alex Frankos (01:32): "Powell has come under increasing pressure over the central bank's take-it-slow approach to cutting interest rates."
Presidential Pressure and Market Implications (01:34)
Trump is pushing Powell and the Fed Board to implement rate cuts sooner than planned, arguing that the economy can handle higher rates and inflation remains too high. This contention has led to Trump publicly criticizing Powell, thereby intensifying the call for immediate monetary policy adjustments.
Unknown Speaker (01:36): "Trump has been railing against him and calling him names and really putting pressure on the Fed to cut rates sooner."
Potential Candidates and Market Uncertainty (02:03)
Several names are being considered for the position, including former Fed Governor Kevin Warsh, National Economic Council Director Kevin Hassett, and Treasury Secretary Scott Besant. Chelsea Delaney highlights that naming a successor nearly a year before Powell's term ends is unprecedented and could lead to market unpredictability.
Chelsea Delaney (02:05): "Naming someone 10 or 11 months before the end of Powell's term, which is next May, would create this kind of backseat driver effect."
This early nomination can signal potential policy shifts to the markets, possibly leading to abrupt changes in fiscal strategies and making the economic landscape more volatile.
2. Pharmaceutical Trade Dynamics: Ireland’s Economic Influence and U.S. Tariffs
Ireland’s Dominance in Pharma Exports (05:42)
Chelsea Delaney reports on the significant surge in U.S. imports of pharmaceutical ingredients from Ireland, particularly those used in obesity and diabetes drugs like Mountjaro and Wegovy. This influx has contributed substantially to the U.S. trade deficit and has caught President Trump's attention regarding potential tariff implementations.
Alex Frankos (06:23): "Ireland has sent about $36 billion worth of those drugs to the US this year. All of that has flown on planes, and almost all of that has gone to Indiana, where Eli Lilly is based."
Economic Growth and Vulnerability (07:08)
Ireland's economy experienced nearly 10% growth in the first quarter, largely driven by its role as a production hub for major U.S. pharmaceutical and tech companies. However, this growth makes Ireland's economy vulnerable to U.S. tariffs, as Trump aims to repatriate manufacturing and reduce dependence on foreign production.
Alex Frankos (07:18): "Ireland's economy grew almost 10% in the first quarter... It has this very special role in the global operations of a lot of US Companies."
Tariff Implications and Industry Response (08:16)
The White House is contemplating tariffs on pharmaceutical products and their ingredients after a Section 232 investigation. Companies like Eli Lilly and Merck are considering rebalancing their production strategies in response to potential tariffs, which could undermine the cost advantages currently enjoyed by manufacturing in Ireland.
Alex Frankos (08:19): "This could definitely undercut the logic of that [offshore production]."
While these companies have deep-rooted operations in Ireland, the looming tariffs pose a significant threat to their cost structures and long-term strategies.
3. Vaccine Advisory Reforms in the U.S.
New Vaccine Panel Formation (02:44)
The podcast shifts to public health, highlighting the establishment of a new vaccine advisory committee under Health Secretary Robert F. Kennedy Jr. This panel is tasked with reexamining vaccine recommendations for children and teenagers, focusing on hepatitis B and MMR (measles, mumps, and rubella) vaccines.
Dr. Martin Kulldorf (04:15): "Secretary Kennedy has given this committee a clear mandate to use evidence-based medicine when making vaccine recommendations."
Addressing Vaccine Hesitancy (04:43)
Dr. Kulldorf emphasizes the importance of nuanced vaccine evaluations, moving away from polarized views that consider vaccines as entirely safe or dangerous. The panel aims to provide balanced, evidence-based recommendations to foster public trust and informed decision-making.
Dr. Martin Kulldorf (04:15): "Vaccines are not all good or bad. If you think that all vaccines are safe and effective and want them all, or if you think that all vaccines are dangerous and don't want any of them, then you don't have much use for us."
The panel is set to review concerns such as preservatives allegedly linked to autism, reflecting ongoing debates between public health officials and anti-vaccine activists.
4. Technology Sector Developments: Nvidia’s Expansion into Cloud Computing
Nvidia’s Market Surge and Strategic Moves (11:23)
Asa Fitch reports on Nvidia's remarkable growth, with its shares reaching a record high and surpassing Microsoft as the largest company by market capitalization. Nvidia is leveraging its dominance in AI chip production to expand into cloud computing, challenging established giants like Amazon, Microsoft, and Google.
Asa Fitch (11:23): "For Nvidia, it's a fertile area for them to grow into. They launched a cloud computing business a couple of years ago called DGX Cloud."
Competitive Landscape and Future Prospects (11:57)
Nvidia is staking its claim in cloud services by investing in AI-specialized companies such as Corowe and Lambda. This strategic positioning threatens the profitability of existing cloud leaders, who may face increased competition and potentially reduced margins.
Asa Fitch (11:57): "Nvidia is starting to ruffle feathers with Microsoft and fellow tech giants Amazon and Google by moving into cloud computing."
Nvidia's aggressive expansion into cloud computing not only diversifies its revenue streams but also positions the company as a formidable competitor in an industry characterized by high profit margins and established player dominance.
5. Energy Sector Update: Shell and BP Takeover Talks Denied
Shell Denies Takeover Talks with BP (09:38)
In the energy sector, Shell has publicly denied involvement in takeover negotiations with its UK rival, BP. This statement follows a Wall Street Journal report suggesting that Shell was in early-stage discussions to possibly acquire BP. Shell clarified that it's now bound by UK takeover regulations, restricting any potential offer for BP unless mutually agreed upon by both companies' boards.
6. Aerospace Dynamics: Jeff Bezos and Elon Musk’s Space Ventures
Blue Origin’s Strategic Discussions with the White House (09:38)
The episode also explores the evolving dynamics between aerospace magnates Jeff Bezos and Elon Musk. Blue Origin, founded by Bezos, has engaged in discussions with President Trump and his administration, seeking increased government contracts. This move comes amid Musk's SpaceX facing potential setbacks, including the rescinding of a NASA nomination and possible cancellation of government contracts as Trump considers cost-saving measures.
Luke Vargas (10:08): "We are exclusively reporting that the founder of space company Blue Origin has spoken to Trump at least twice this month."
These developments suggest a potential shift in the competitive landscape of the space industry, with Blue Origin positioning itself to capitalize on any changes resulting from Musk's strained relationship with the current administration.
7. Market Implications and Future Outlook
The episode concludes by underscoring the interconnectedness of these diverse sectors and their collective impact on global markets. From monetary policy shifts and international trade tensions to technological advancements and public health reforms, each topic presents significant implications for investors, policymakers, and the broader economy.
Closing Remarks
Produced by Daniel Bach and Kate Bullivant, with supervising producer Sandra Kilhoff, Luke Vargas wraps up the episode by reiterating the importance of staying informed on these critical developments. The comprehensive coverage ensures listeners are well-equipped to navigate the complexities of today's rapidly changing news landscape.
Notable Quotes:
- Alex Frankos (01:32): "Powell has come under increasing pressure over the central bank's take-it-slow approach to cutting interest rates."
- Chelsea Delaney (02:05): "Naming someone 10 or 11 months before the end of Powell's term, which is next May, would create this kind of backseat driver effect."
- Dr. Martin Kulldorf (04:15): "Vaccines are not all good or bad. If you think that all vaccines are safe and effective and want them all, or if you think that all vaccines are dangerous and don't want any of them, then you don't have much use for us."
- Asa Fitch (11:23): "For Nvidia, it's a fertile area for them to grow into. They launched a cloud computing business a couple of years ago called DGX Cloud."
Timestamp Highlights:
- 00:59: Introduction to Trump’s early Fed Chair nomination.
- 05:42: Detailed analysis of Ireland’s pharmaceutical exports and potential U.S. tariffs.
- 11:23: Nvidia’s expansion into cloud computing and its market impact.
This comprehensive summary encapsulates the multifaceted discussions of the WSJ "What's News" podcast, providing listeners with a clear and detailed overview of the episode's key points and insights.